Verofax and Jawraa Partner to Revolutionize Customer Experience with Holobox AI Agent

Verofax and Jawraa Partner to Revolutionize Customer Experience with Holobox AI Agent

DUBAI, UAE, Oct 25, 2024 - (ACN Newswire via SeaPRwire.com) - Verofax, a leading provider of cutting-edge customer service solutions, today announced the signing of a Memorandum of Understanding (MoU) with Jawraa, a renowned telecom and digital services company in Saudi Arabia. This strategic partnership aims to elevate customer experiences by introducing Verofax’s advanced Holobox AI agent and in-app AI agent solutions, tailored to meet the needs of government institutions and large enterprises.The collaboration between Verofax and Jawraa is set to redefine customer service in the digital era by enabling seamless, AI-powered interactions that bridge the gap between physical and virtual engagement. The Holobox AI agent provides immersive, holographic support for in-person interactions, while the in-app AI agent delivers intelligent, personalized assistance within mobile applications. Both solutions are designed to enhance customer engagement, streamline operations, and optimize service delivery across industries.Strength of the PartnershipJawraa brings a wealth of expertise to the partnership, leveraging its extensive relationships with telecom giants and enterprises in Saudi and across the Middle East. The company's robust portfolio of digital solutions and telecom services positions it as a key player in driving digital transformation for governments and large-scale enterprises. Known for fostering innovative technology partnerships, Jawraa has consistently demonstrated its capacity to scale and implement sophisticated solutions that meet the dynamic demands of modern businesses.Verofax, with its innovative AI-powered solutions, aims to transform customer experiences through augmented reality (AR) and artificial intelligence (AI) technologies. Recently, the company secured $3 million in bridge funding, reaffirming its commitment to deploying AI and AR experiences that enhance user engagement across various sectors, including tourism and sports. Verofax’s partnership with Jawraa marks a significant milestone in its growth trajectory as it continues to pioneer advanced customer service technologies.Enhancing Customer Experience through AI InnovationDr Sulaiman Al-Turki CEO of Jawra said: “The introduction of Holobox and in-app AI agents will provide customers with a new level of convenience and interactivity. These AI-driven tools are designed to handle complex inquiries, provide real-time support, and personalize customer journeys, resulting in faster resolution times and improved satisfaction levels. The solutions will be particularly beneficial for sectors that rely on high-touch customer interactions, such as government services, telecom, and large-scale enterprises”Mr. Wassim Merheby CEO/ Cofounder of Verofax, commented, "Our partnership with Jawraa guarantees elevated customer service for public companies and enterprises to promote sales and awareness on clients’ services. By partnering with Jawraa and showcasing the service on Saudi Export Development authority during Gitex 2024 in Dubai, we received a huge interest from prospects seeking next-generation customer experiences for enterprises and governments alike."About JawraaSince 2005, Jawraa has been a driving force in digital transformation, empowering businesses and governments with innovative solutions.As a leading digital services and telecom company, Jawraa partners with global tech giants like SAP and Microsoft to deliver cutting-edge services in cloud computing, AI, and more. Trusted by top enterprises and Saudi ministries, Jawraa plays a pivotal role in shaping the digital future of the Middle EastAbout VerofaxVerofax is a technology innovator specializing in AI and AR solutions that elevate customer experiences and streamline business operations. By integrating cutting-edge AI tools, Verofax enables enterprises to provide personalized, efficient, and immersive customer interactions. Verofax continues to drive growth and innovation, having recently secured $3 million in funding to expand its AI and AR capabilities across various sectors. Verofax is a portfolio company of Sanabil PIF, KAUST, Plug & Play, 500 startup, Hub71 and other leading VCs globally offering its services to Fortune 100 companies across 50 markets.Learn more at https://www.jawraa.com/ and https://verofax.com/ or contact info@verofax.com. Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Machine learning can predict the mechanical properties of polymers

Machine learning can predict the mechanical properties of polymers

TSUKUBA, Japan, Oct 25, 2024 - (ACN Newswire via SeaPRwire.com) - Polymers such as polypropylene are fundamental materials in the modern world, found in everything from computers to cars. Because of their ubiquity, it’s vital that materials scientists know exactly how each newly developed polymer will perform under different preparation conditions. Thanks to a new study, which was published in Science and Technology of Advanced Materials, scientists can now use machine learning to determine what to expect from a new polymer.Machine learning predicts the material properties of new polymers with high accuracy, providing a nondestructive alternative to conventional polymer testing methods.Predicting the mechanical properties of new polymers, such as their tensile strength or flexibility, usually involves putting them through destructive and costly physical tests. However, a team of researchers from Japan, led by Dr. Ryo Tamura, Dr. Kenji Nagata, and Dr. Takashi Nakanishi from the National Institute for Materials Science in Tsukuba, showed that machine learning can predict the material properties of polymers. They developed the method on a group of polymers called homo-polypropylenes, using X-ray diffraction patterns of the polymers under different preparation conditions to provide detailed information about their complex structure and features.“Machine learning can be applied to data from existing materials to predict the properties of unknown materials,” Drs. Tamura, Nagata, and Nakanishi explain. “However, to achieve accurate predictions, it’s essential to use descriptors that correctly represent the features of these materials.”Thermoplastic crystalline polymers, such as polypropylene, have a particularly complex structure that is further altered during the process of molding them into the shape of the end product. It was, therefore, important for the team to adequately capture the details of the polymers’ structure with X-ray diffraction and to ensure that the machine learning algorithm could identify the most important descriptors in that data.The new method accurately captured the structural changes of commonly used plastic Polypropylene during the molding process into the end product.To that end, they analysed two datasets using a tool called Bayesian spectral deconvolution, which can extract patterns from complex data. The first dataset was X-ray diffraction data from 15 types of homo-polypropylenes subjected to a range of temperatures, and the second was data from four types of homo-polypropylenes that underwent injection molding. The mechanical properties analysed included stiffness, elasticity, the temperature at which the material starts to deform, and how much it would stretch before breaking.The team found that the machine learning analysis accurately linked features in the X-ray diffraction imagery with specific material properties of the polymers. Some of the mechanical properties were easier to predict from the X-ray diffraction data, while others, such as the stretching break point, were more challenging.“We believe our study, which describes the procedure used to provide a highly accurate machine learning prediction model using only the X-ray diffraction results of polymer materials, will offer a nondestructive alternative to conventional polymer testing methods,” the NIMS researchers say.The team also suggested that their Bayesian spectral deconvolution approach could be applied to other data, such as X-ray photoelectron spectroscopy, and used to understand the properties of other materials, both inorganic and organic.“It could become a test case for future data-driven approaches to polymer design and science,” the NIMS team says.Further informationRyo TamuraNational Institute for Materials Science (NIMS)tamura.ryo@nims.go.jpKenji NagataNational Institute for Materials Science (NIMS)nagata.kenji@nims.go.jpTakashi NakanishiNational Institute for Materials Science (NIMS)nakanishi.takashi@nims.go.jpPaper: https://doi.org/10.1080/14686996.2024.2388016About Science and Technology of Advanced Materials (STAM)Open access journal STAM publishes outstanding research articles across all aspects of materials science, including functional and structural materials, theoretical analyses, and properties of materials. https://www.tandfonline.com/STAM Dr Yasufumi NakamichiSTAM Publishing DirectorEmail: NAKAMICHI.Yasufumi@nims.go.jpPress release distributed by Asia Research News for Science and Technology of Advanced Materials. Copyright 2024 ACN Newswire via SeaPRwire.com.
More

媒体撤回侨雄国际涉嫌操纵股价报道

香港, 2024年10月25日 - (亚太商讯 via SeaPRwire.com) - 相关媒体发布报道质疑侨雄国际(00381.HK)涉嫌操纵股价事件迎来后续。在收到侨雄国际通过律师事务所发出的律师函后,媒体已经主动撤回报导。有财经媒体于10月22日在平台发布题为《16个交易日翻了近30倍,侨雄国际(00381)全靠两个"经纪商"雄起?》的文章,指出截至10月21日,中国北方证券和长桥证券两个经纪商近20个交易日分别净买入了0.92亿股和0.27亿股,持股比例分别为14.02%及3.42%,而其他经纪商仅有少量买入,由此质疑公司股价存在被操纵的嫌疑。值得关注的是,该报导发布前并未与侨雄国际做任何的沟通与确认,仅凭市场交易券商名字片面的指责怀疑公司操纵市场,新闻客观性存在一定的瑕疵。结合近期侨雄国际股价出现大幅上涨,上述报道引发市场关注。侨雄国际在10月23日盘后在港交所发布澄清公告,否认报道中包含的猜测并认为该报道不准确且具有误导性。同时公司在公告中重申报导中之指控毫无理据,含有误导性陈述、恶意及虚假指控及明显事实错误,公司将对其新闻前恶意做空行为和新闻后操纵市场行为发出律师函和诉讼,以维护广大投资者权益。侨雄国际随后通过律师事务所向媒体发出律师函进行沟通,对其郑重表达相关意见与诉求,并于10月25日收到复函。相关媒体在复函中表示,上述报道仅是对于盘面和席位变动所做出的合理怀疑,秉持着善意原则,公司将会在发函的24小时内,将题为《16个交易日翻了近30倍,侨雄国际(00381)全靠两个"经纪商"雄起?》的文章从智通财经平台撤下。经记者查询显示,该报道目前已经无法打开。侨雄国际今日盘后再次发布公告称,经公司代表律师与媒体沟通过后,有关媒体已同意持善意原则并已主动撤回该等媒体报导。根据董事会成员李立中表示,已于2024年10月23日向媒体就报导作出澄清,除上述外没有其他补充,提醒公司股东及其他投资者于买卖公司证券时务审慎行事。 Copyright 2024 亚太商讯 via SeaPRwire.com.
More
Military Metals Adds Key Ground at Its West Gore Antimony Property, Signs Binding LOI to Acquire Additional Claims

Military Metals Adds Key Ground at Its West Gore Antimony Property, Signs Binding LOI to Acquire Additional Claims

Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - October 24, 2024) - Military Metals Corp. (CSE: MILI) (OTC Pink: MILIF) (FSE: QN90) (the "Company" or "Military") announces it has signed a binding LOI to acquire further claims surrounding its West Gore Antimony Project ("West Gore" or the "Project") to consolidate the mineralized area. West Gore is a brownfield project with past production, historical high-grade drill results include 7.07 metres of 10.6 gpt gold and 3.4% antimony. During a period of production, it was Canada's most prominent antimony mine.West Gore consists of four Exploration Licenses comprising 585 hectares located in Hants County, Nova Scotia, Canada, and the newly acquired ground adds 388 hectares to the immediate northwest of the Project, comprising the balance of the West Gore antimony-gold mineralized system and its historical mine workings. The Company has a three-year option to acquire a 100% interest in the licenses for $235,000 spread over the term and the sellers will receive a 3% Net Smelter Royalty ("NSR") with standard buy-back provisions. It is anticipated the Company will announce the Definitive Agreement within ten days.The historical West Gore mines have a mining history dating back to 1883 and were a significant source of antimony during the First World War, most of which was shipped to England. Total production of gold and antimony between 1883 and 1917, the last recorded year of production, remains unknown. However, between 1914 and 1917 alone, nearly 32,000 metric tons were mined yielding over 7,000 metric tons of antimony concentrate grading 46% antimony. The total amount of gold recovered up to 1917 was estimated to be nearly 6,900 ounces. Aside from minor exploration work in the 1960s, the 1980s, and again over the past few years, the West Gore system remains essentially unexplored.With the acquisition of the new claims the Company has gained complete coverage over the entire mineralized system including all the historical mine workings and known antimony-gold occurrences with additional ground along trend in both directions as exhibited in Map 1 below. This in turn enables the Company to approach this antimony-gold system in its entirety to unlock future value. All relevant data are in the process of being compiled into an integrated digital database, with exploration plans to follow.Map 1: West Gore Project ClaimsTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10818/227668_841965127489abc4_001full.jpgAntimony-gold mineralization at West Gore is hosted in graphitic and sulfide-bearing slates of the lower units of the Cambrian-age Halifax Formation that were deformed into a northeast-trending, upright, closed syncline and metamorphosed to greenschist facies during the regional Acadian orogeny. Mineralization occurs as stibnite, native antimony, aurostibnite, and antimony-gold alloys and oxides. Whereas the fold belt strikes northeast-southwest, mineralized structures trend northwest-southeast.The technical contents of this release were reviewed and approved by Avrom E. Howard, MSc, PGeo, geological consultant to Military Metals and a qualified person as defined by National Instrument 43-101.Investor Relations EngagementOn October 23, 2024, the Company engaged Clarkham Capital ("Clarkham") to provide investor relations services with a focus on the German stock market and the German-speaking investment community in support of the company listing on the Frankfurt Stock Exchange (the "Clarkham Agreement"). Pursuant to the terms of the Clarkham Agreement, Clarkham will, among other items, provide the Company with marketing services, which includes social media management, content creation, distribution, digital marketing, including, but not limited to, the preparation of articles and coverages on multiple financial platforms and newsletters, and translation and distribution of press releases in Germany and any other marketing services as agreed upon by the Company and Clarkham (the "Services"). The Clarkham Agreement has a term of two (2) months and is anticipated to commence on or about October 24, 2024. The Company will make a one-time payment to Clarkham of EUR 200,000 (CAD$298,340), as consideration for the Services. Sebastian Korbach will be providing the Services to the Company on behalf of Clarkham and may be contacted at +44-20-38839398 or cc@clarkham.com, or Flat 285, 61 Praed Street, London, UK W2 1ns. The Company will not issue any securities to Clarkham as compensation. Both Clarkham and Sebastian Korbach are arm's length to the Company and do not have any interest, direct or indirect, in the Company or its securities nor do they have any right to acquire such an interest.About Military Metals Corp. The Company is a British Columbia-based mineral exploration company that is primarily engaged in the acquisition, exploration and development of mineral properties with a focus on antimony.ON BEHALF OF THE BOARD OF DIRECTORSFor more information, please contact:Scott EldridgeCEO and Directorscott@militarymetalscorp.comFor enquiries, please call 604-722-5381 or 604-537-7556This news release contains "forward-looking information". Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-Looking information in this news release includes statements related to the completion of the acquisition of the Target by Military, as well as future plans for exploration activities, and assumptions related to the continuation of the global demand for antimony. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this news release. These include entry into a definitive agreement in respect of the Acquisition, meeting the conditions to close the Acquisition, geopolitical developments related to the supply of antimony, the continued use of antimony and availability of alternatives, availability of capital and labour in respect of the properties that are the subjects of this news release, the results of any future exploration activities, which cannot be guaranteed, and such other factors as may impact both the Acquisition and any future activities in respect of the properties held by the Target. Additional risk factors can also be found in the Company's public filings under the Company's SEDAR+ profile at www.sedarplus.ca. Forward-Looking statements contained herein are made as of the date of this news release and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results or otherwise. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward looking statements if circumstances, management's estimates or opinions should change, except as required by securities legislation. Accordingly, the reader is cautioned not to place undue reliance on forward-looking statements.The Canadian Securities Exchange has neither approved nor disapproved the information contained herein and does not accept responsibility for the adequacy or accuracy of this news release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/227668 Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Kryterion Strengthens Japan Operations to Enhance Client Service Capabilities

Kryterion Strengthens Japan Operations to Enhance Client Service Capabilities

TOKYO, October 25, 2025 - (ACN Newswire via SeaPRwire.com) - Kryterion Inc. announces the expansion of its Japan operations in an exciting move that will extend its software as a service (SaaS) certification and assessment software services for new and existing clients headquartered in Japan, reinforcing its commitment to client service excellence."Kryterion is set to be a premier provider of Japanese-language test delivery and locally staffed support services in Japan and for the international community," says William Dorman, Kryterion Chairman. "Simultaneously, we will introduce our highly secure, computer-based assessment management services to Japanese organizations serving the dynamic Japanese marketplace and the wider international community. Kryterion has a proven track record in transitioning from paper-based testing to computer-based testing and from onsite computer-based testing to secure, internet-based, proctored testing."Kryterion is a leading SaaS digital test development and test delivery provider in international markets, with approximately 1000 test center affiliates. It introduced secure, online proctored (OLP) exam delivery with a lockdown browser in 2007 and today provides global assessment services support, including Japanese language testing in Japan. Kryterion a subsidiary of the Drake International Group, which, through its subsidiaries, possesses a presence in 13 countries, including Japan, Korea, Taiwan, Hong Kong, Singapore, the Philippines, New Zealand, and Australia. Currently, Drake International's largest subsidiary in Japan is Drake Business Services Asia (DBSA). Led by CEO Grant Mackenzie, the company has been active in Japan since 2017. DBSA is a leading managed services provider, offering complete outsourced management of non-core support functions to deliver measurable cost reductions and efficiency improvements.According to Dorman, "The success of Drake Business Services Asia in Japan and across the region, coupled with growing acceptance of Kryterion's highly secure digital test development and test delivery services - especially in Japan's high technology sector - have prompted our decision to expand Kryterion's current presence in Japan dramatically."Contact Information:Yoshinori Nambo, Japan Sales Manager, Kryterion, Inc.Email: ynambo@KryterionOnline.com Website: www.Kryterion.com Buzz Walker, Chief Revenue Officer, Kryterion, Inc.Email: bwalker@KryterionOnline.com Website: www.Kryterion.com Copyright 2024 ACN Newswire via SeaPRwire.com.
More
LIGHTS and SOUNDS at the JBL Rewind Revolution Roadshow

LIGHTS and SOUNDS at the JBL Rewind Revolution Roadshow

KUALA LUMPUR, MALAYSIA, Oct 24, 2024 - (ACN Newswire via SeaPRwire.com) - JBL®, the renowned lifestyle audio brand under Harman International, celebrated the launch of the “JBL Rewind Revolution Roadshow” today, bringing the party to life with its portable JBL PartyBox speakers and JBL PartyLight. Using AuracastTM technology, JBL PartyBox and JBL PartyLight sync seamlessly with each other and the music, creating a next-level sensory experience.JBL PartyLight BeamJBL PartyLight StickFor a more personal experience, the flagship True Wireless Stereo (TWS) earbuds, JBL Tour Pro 3, which is the first TWS with Auracast by JBL, rocketed onto the roadshow, with a Smart Charging Case with feature rich touchscreen, Real-Time True Adaptive Noise Cancelling and new audio transmitter for in-flight. The JBL Rewind Revolution Roadshow runs from 21-27 October at Mid Valley Mega Mall, East Entrance Atrium.The latest products designed to elevate your get-together or events are the JBL PartyLight Beam and JBL PartyLight Stick. While both add dynamic lighting synced to the best of the music, the JBL PartyLight Beam is a compact unit ideal for kinetic lighting effect. The JBL PartyLight Stick stands around one meter tall, is great for adding 330º room-filling mood enhancing features to your playlist. Both products use AuracastTM technology to connect effortlessly to a JBL PartyBox with a simple push of a button on each device. Control the speed, colours and patterns from the JBL PartyBox app. The built-in microphone with music detection algorithm, allows JBL PartyLight Beam and JBL PartyLight Stick to sync to the music playing in the room.The roadshow also featured JBL Partybox Club 120 and JBL PartyBox Stage 320, showcasing impressive JBL Pro Sound, sub-grille lights, and battery-powered performance. Whether it is dance or R&B, JBL PartyBox speakers deliver JBL’s renowned high-quality sound. These portable speakers come with a plethora of controls and features from the product-topping control panel, built-in handle, replaceable battery, IPX4 splashproof resistance, microphone and guitar inputs, plus Bluetooth to connect to your favourite music app from your preferred device.Mr. Henry Yap, Managing Director of Global Best United (M) Sdn Bhd said, “You can now party outside the box and enter a whole new soundscape with JBL PartyLight Beam and JBL PartyLight Stick as your essential elements for creating unforgettable parties. Whether it’s a holiday party or an intimate evening, synchronised music and lights can set the perfect mood.”“While JBL PartyBox Club 120 and JBL PartyBox Stage 320 can be paired with JBL PartyLight Stick and JBL PartyLight Beam, it is also very versatile and sturdy for use outdoor and indoor. Both comes with powerful JBL Pro Sound, futuristic lightshow, and splash proof, you can use it as a speaker or add a microphone, you can take your karaoke parties and outdoor celebrations to the next level”, Henry added.Mr. Mitchell Wong, Business Development Manager for JBL Malaysia said, “The technological advancements of the JBL Tour Pro 3 offer a feature-rich, fully customisable system. The JBL Tour Pro 3 is the flagship TWS earbud from JBL, with the latest audio technology like JBL Spatial 360 with Head Tracking, True Adaptive Noise Cancellation 2.0 and the first dual driver earbud.”The dual-driver design in the JBL Tour Pro 3 enhances audio performance, reducing distortion and improving sound clarity. The True Adaptive Noise Cancellation 2.0 system monitors and recalibrates over 50,000 times per second, recalibrating to adapt to environmental changes and compensating for sound leakage. The earbuds also ship with five additional ear-tips options - four silicon and one foam - for enhanced comfort and fit. Available in two colours, black and latte, the JBL Tour Pro 3’s smart case screen can be personalised with a photo, wallpaper and supports 13 languages.Availability. All featured JBL® products are available for purchase at Lazada, Shopee, and all leading retailers:ALL IT, Viewnet, Urban Republic, Thundermatch, Vivid Concepts, PC Image, SY Electric, THT, One Living, Harvey Norman, AES, Central Electronics, SS Audio, Brightstar Computers, Style Laser and EKS.Find out more about the JBL Products at https://www.jblonlinestore.com.my.Hi-Res Images. Please download hi-res product and lifestyle images from this link.For media information, kindly contact:Triven Marketing Group, for JBL® MalaysiaJazzmin WanEmail: j.wan@swanconsultancy.biz Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Governments, Law Enforcement, and Industry Leaders to Convene at Global Anti-Scam Summit Americas 2024 in Washington D.C.

Governments, Law Enforcement, and Industry Leaders to Convene at Global Anti-Scam Summit Americas 2024 in Washington D.C.

Washington, D.C., Oct 25, 2024 - (ACN Newswire via SeaPRwire.com) - Online scams wreak havoc across the Americas and globally, causing significant financial and emotional damage. The Global Anti-Scam Summit (GASS) Americas 2024, organized by the Global Anti-Scam Alliance (GASA) and hosted by Amazon.com, Inc., aims to combat these growing threats. The summit will feature over 30 hours of presentations, workshops, and interactive sessions across ten critical tracks, all focused on developing a global defense strategy to protect consumers and inform regulation.The summit will empower experts to take decisive action by focusing on the impact on victims, highlighting global scam statistics, explaining emerging scam tactics, and fostering international cooperation. The aim is to provide a roadmap for regulatory bodies to drive meaningful change.With $1.026 billion in global scam losses in 2023, this event seeks to mitigate further damage in 2024 and beyond.Day 1 will address the human and policy aspects of scams:Victim Impact: Led by AARP, this session delves into the emotional and financial toll on victims and their communities.Policy: The Aspen Institute will explore regulatory gaps and legislative solutions, sharing best practices from around the world.Law Enforcement: Chaired by UNODC, this session focuses on the collaboration between local and international agencies to disrupt scam networks.Data & Signal Sharing: GASA and DNS Research Federation will unveil plans for an international cybercrime exchange to reduce cybercrime by 50% in 10 years.Bank Collaboration: This session, led by Feedzai, will explore the critical role of banks in preventing scams.Day 2 will shift to specific industries and technologies most at risk:Financial Services: Featuring industry leaders like Capital One and Mastercard, this session will explore how multi-sector collaboration can build the perfect anti-fraud infrastructure.Telecom: Focuses on how telecom companies can improve security to protect consumers.Customer Digital Experience: Major platforms like Amazon will discuss how to strengthen protections at key digital touchpoints.Blockchain: Investigating scams in crypto and blockchain, chaired by Cube3.AI.Cybersecurity: Trend Micro will lead panels on advanced investigation techniques, focusing on scams like sextortion and pig butchering.Uniting Expertise for a Scam-Free Future"Consumers globally are facing a crisis with scams. Governments, private industry, and law enforcement must come together and act now," says Jorij Abraham, Managing Director of GASA. "Our aim at this summit is not only to discuss the problems but to build solutions that protect consumers worldwide."Confirmed Speakers:Glen Prichard, UNODCJean-Jacques Sahel, GoogleMatthew Noyes, U.S. Secret ServiceLaura Quevedo, MastercardBen Chance, ZelleAmy Nofziger, AARPMauro Ellovitch, MPMGThe summit will also launch the annual Global State of Scams Report 2024, offering an in-depth analysis of major scam trends and their impact.Join us in Washington, D.C., for this landmark event. Visit gasa.org/gass-2024-americas to view the full schedule and register.Contact InformationSam RogersMarketing Director, Global Anti-Scam Alliancesam.rogers@gasa.orgSOURCE: Global Anti-Scam Alliance (GASA) Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Vyasa Yoga SG Marks Silver Jubilee with International Wellness Conference

Vyasa Yoga SG Marks Silver Jubilee with International Wellness Conference

SINGAPORE, Oct 25, 2024 - (ACN Newswire via SeaPRwire.com) - Vyasa Yoga SG, Singapore’s leading yoga institute, proudly celebrated its Silver Jubilee this month, marking 25 years of transforming lives through yoga and holistic health practices. Founded with S-VYASA, Vyasa Yoga SG has empowered thousands through its scientific, research-based yoga training and therapy programs, building a community of 3,000 certified yoga instructors and 500 yogi health therapists.The Silver Jubilee celebrations were inaugurated by esteemed guests, including Deputy High Commissioner of India Pooja Tillu, Neil Parekh, Chairman of Singapore Indian Chamber of Commerce and Industry (SICCI), Dr. H R Nagendra Guruji, Padma Shri awardee and renowned yoga guru, and Dr. Manjunath NK, Vice-President of the Asian Yoga Therapy Association, alongside Vyasa Yoga SG Founder, Manoj Thakur.To commemorate the milestone, Vyasa Yoga SG hosted the **International Conference on "Comprehensive Wellness Strategy" from October 19th to 20th, 2024 at the Galaxy Ballroom, CSC Tessensohn Club. The conference brought together 50 experts from 11 countries to explore integrating ancient yoga wisdom with modern science to enhance well-being. In her keynote address, Deputy High Commissioner Pooja Tillu emphasized the global relevance of yoga, stating: “Continue embracing yoga practice as a guiding light that will bring us together as a global family.”Manoj Thakur, Founder of Vyasa Yoga SG, reflected on the institute’s journey, “It has been a remarkable 25-year journey. Our success reflects the spirit of well-being we have cultivated in Singapore and beyond. We look forward to guiding people towards healthier, happier lives for many more years to come.”The event featured live yoga demonstrations and a special recognition ceremony to honor the institute’s significant contributions to health and wellness in Singapore. Vyasa Yoga SG is planning a series of events throughout the year to celebrate its 25th anniversary.About Vyasa Yoga SGEstablished to promote a healthy lifestyle through a scientific approach to yoga, Vyasa Yoga SG offers a variety of accredited programs for all ages and levels. With a mission to foster a culture of well-being, the institute continues to be at the forefront of holistic health in Singapore. For more information, visit https://vyasasingapore.com/. For further media queries contact:Ganesh Somwanshiganesh@mettai.world Copyright 2024 ACN Newswire via SeaPRwire.com.
More

Everest Medicines Announces the Launch of VELSIPITY(R) in the Guangdong-Hong Kong-Macau Greater Bay Area

SHANGHAI, Oct 25, 2024 - (ACN Newswire via SeaPRwire.com) - Everest Medicines (HKEX 1952.HK, “Everest”, or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that, through the "Hong Kong and Macau Medicine and Equipment Connect" policy, VELSIPITY(R) has officially been approved for patients with moderately to severely active ulcerative colitis (UC) by the Guangdong Provincial Medical Products Administration and can first be used in the Foshan Fosun Chancheng Hospital and the First Affiliated Hospital of Sun Yat-sen University, two of the medical institutions designated by the "Hong Kong and Macau Medicine and Equipment Connect" policy in the Greater Bay Area. Subsequently, VELSIPITY(R) will be introduced in other qualified hospitals under the connect policy. VELSIPITY(R) is now the third commercialized product of Everest Medicines.VELSIPITY(R) is an innovative advanced therapy that was officially approved by the Pharmaceutical Administration Bureau of Macau in April 2024. It is an oral treatment taken once daily for the treatment of patients aged 16 and above with moderately to severely active UC. UC is a chronic, relapsing, non-specific inflammatory disease, and as the disease progresses, the risk of disability and colorectal cancer incidence continues to rise. By 2030, the number of patients with UC in China is expected to more than double compared to 2019, reaching approximately 1 million, with a significant unmet need for innovative therapies.“The launch of VELSIPITY(R) in the Greater Bay Area accelerates the access to this advanced therapy in mainland China, offering a new option for patients with moderately to severely active UC." Said Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines. “Everest Medicines is committed to expeditiously delivering innovative therapies to patients. Moving forward, we will keep leveraging our strengths and exploring innovative ways to improve the accessibility of these therapies. We plan to have VELSIPITY(R) submitted for new drug application in mainland China by the end of this year, further enhancing its accessibility and benefiting more patients." VELSIPITY(R) was developed by Arena Pharmaceuticals, which was acquired by Pfizer in 2022. Everest Medicines obtained exclusive rights to develop, produce, and commercialize VELSIPITY(R) in Greater China and South Korea from Arena as early as 2017. As a core product in the field of autoimmune diseases for Everest Medicines, VELSIPITY(R) was successively approved in Macau and Singapore in the first half of this year and was approved in the United States and the European Union in October last year and February this year, respectively. In addition, Everest Medicines recently submitted an new drug application for VELSIPITY(R) in Hong Kong, China.VELSIPITY(R) is the first and only advanced oral UC therapy approved for use in patients 16 years of age or older in the EU, and the ELEVATE UC 52 and ELEVATE UC 12 were the only studies of advanced therapies for UC to include patients with isolated proctitis. In the results of the Asian multi-center Phase 3 clinical trial of VELSIPITY(R) for the treatment of moderately to severely active UC announced in July this year, VELSIPITY(R) achieved positive topline data results in both the induction and maintenance treatment periods, with good safety profile, and is convenient to take once a day, providing further solid scientific basis and support for the wide application of the drug in clinical practice.About VELSIPITY(R) (etrasimod)VELSIPITY(R) is a once-daily, oral, sphingosine 1-phosphate (S1P) receptor modulator that selectively binds with S1P receptor subtypes 1, 4, and 5. Regulatory approvals have been granted in US, EU, Canada, Australia, Singapore, UK, Switzerland, Israel and Macau for VELSIPITY(R) in ulcerative colitis.About Everest MedicinesEverest Medicines is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines that address critical unmet medical needs for patients in Asian markets. The management team of Everest Medicines has deep expertise and an extensive track record from both leading global pharmaceutical companies and local Chinese pharmaceutical companies in high-quality discovery, clinical development, regulatory affairs, CMC, business development and operations. Everest Medicines has built a portfolio of potentially global first-in-class or best-in-class molecules in the company’s core therapeutic areas of renal diseases, infectious diseases and autoimmune disorders. For more information, please visit its website at www.everestmedicines.com.Forward-Looking Statements:This news release may make statements that constitute forward-looking statements, including descriptions regarding the intent, belief or current expectations of the Company or its officers with respect to the business operations and financial condition of the Company, which can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “confident” and similar statements. Such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, or other factors, some of which are beyond the control of the Company and are unforeseeable. Therefore, the actual results may differ from those in the forward-looking statements as a result of various factors and assumptions, such as future changes and developments in our business, competitive environment, political, economic, legal and social conditions. The Company or any of its affiliates, directors, officers, advisors or representatives has no obligation and does not undertake to revise forward-looking statements to reflect new information, future events or circumstances after the date of this news release, except as required by law. Copyright 2024 ACN Newswire via SeaPRwire.com.
More

云顶新耀宣布伊曲莫德(VELSIPITY)获批进入粤港澳大湾区 为溃疡性结肠炎患者带来新选择

上海, 2024年10月25日 - (亚太商讯 via SeaPRwire.com) - 云顶新耀(HKEX 1952.HK)是一家专注于创新药研发、临床开发、制造和商业化的生物制药公司,今日宣布,得益于"港澳药械通"政策,伊曲莫德(VELSIPITY(R))正式获得"粤港澳大湾区内地临床急需进口港澳药品批件"批准,可以在佛山复星禅诚医院、中山大学附属第一医院两家大湾区药械通政策指定的医疗机构先行使用,后续该产品将在其他药械通资质医院陆续引入。伊曲莫德成为云顶新耀第三款商业化新药。伊曲莫德是一款创新的先进疗法,于2024年4月获得中国澳门特别行政区药物监督管理局正式批准,每日一次口服,用于治疗16岁及以上中重度活动性溃疡性结肠炎(UC)患者。溃疡性结肠炎是一种慢性、复发性、非特异性炎症性疾病,随着病情延长,致残率和结直肠癌发生率会不断上升。到2030年,中国的溃疡性结肠炎患者人数预计将比2019年增加一倍以上,达到约100万人,患者对创新疗法存在巨大未满足需求。云顶新耀首席执行官罗永庆表示:"非常高兴看到伊曲莫德正式落地粤港澳大湾区,加快了该先进疗法在中国大陆可及,为更多溃疡性结肠炎患者带来治疗新选择。云顶新耀致力于将创新疗法以最快速度带给患者,未来,我们将继续依托国家医药产业政策,发挥自身优势,不断探索创新模式来实现创新疗法的加速落地。预计下半年,我们将在中国大陆地区递交伊曲莫德的新药上市许可申请,以进一步推进伊曲莫德的用药可及性,造福更多患者。"伊曲莫德由Arena Pharmaceuticals公司开发,辉瑞于2022年完成了对Arena Pharmaceuticals的收购,而云顶新耀早在2017年已从Arena获得了在大中华区和韩国开发、生产和商业化伊曲莫德的独家权利。伊曲莫德于去年10月和今年2月先后在美国和欧盟获得新药上市批准。作为云顶新耀自身免疫性疾病领域的重磅产品,伊曲莫德亦于今年上半年陆续在中国澳门、新加坡获得新药上市批准。此外,云顶新耀也于近期在中国香港递交了伊曲莫德的新药上市许可申请。伊曲莫德是欧盟首个且唯一获批用于16岁及以上患者的新一代口服治疗溃疡性结肠炎药物,也是目前唯一在全球Ⅲ期临床试验中证实对孤立性直肠炎有疗效的药物。在今年7月公布的伊曲莫德治疗中重度活动性溃疡性结肠炎的亚洲多中心Ⅲ期临床研究结果中,伊曲莫德取得了在诱导期和维持期治疗的积极结果,且安全性良好,一天一次口服方便,为该药物在临床实践中的广泛应用进一步提供了坚实的科学依据和支持。关于伊曲莫德(VELSIPITY(R), etrasimod)伊曲莫德(VELSIPITY(R),etrasimod)是一种每日一次口服的高选择性鞘氨醇-1-磷酸(S1P)受体调节剂,采用优化的药理学设计,与S1P受体1、4和5结合。伊曲莫德目前已在美国、欧盟、加拿大、澳大利亚、英国、瑞士、以色列以及中国澳门和新加坡获得新药上市批准。关于云顶新耀云顶新耀是一家专注于创新药研发、临床开发、制造和商业化的生物制药公司,致力于满足亚洲市场尚未满足的医疗需求。云顶新耀的管理团队在中国及全球领先制药企业从事过高质量研发、临床开发、药政事务、化学制造与控制(CMC)、业务发展和商业化运营,拥有深厚的专长和丰富的经验。云顶新耀已打造多款疾病首创或者同类最佳的药物组合,公司的治疗领域包括肾科疾病、感染性和传染性疾病、自身免疫性疾病。有关更多信息,请访问公司网站:www.everestmedicines.com。前瞻性声明本新闻稿所发布的信息中可能会包含某些前瞻性表述,乃基于本公司或管理层在做出表述时对公司业务运营情况及财务状况的现有看法、相信、和现有预期,可能会使用"将"、"预期"、"预测"、"期望"、"打算"、"计划"、"相信"、"预估"、"确信"及其他类似词语进行表述。这些前瞻性表述并非对未来业绩的保证,会受到风险、不确定性及其他因素的影响,有些乃超出本公司的控制范围,难以预计。因此,受我们的业务、竞争环境、政治、经济、法律和社会情况的未来变化及发展等各种因素及假设的影响,实际结果可能会与前瞻性表述所含资料有较大差别。本公司及各附属公司、各位董事、管理人员、顾问及代理未曾且概不承担更新该稿件所载前瞻性表述以反映在本新闻稿发布日后最新信息、未来项目或情形的任何义务,除非法律要求。 Copyright 2024 亚太商讯 via SeaPRwire.com.
More
Founder of Hua Medicine Dr. Chen Li was awarded the  ‘C.C. Tan Life Science Industrialization Award’

Founder of Hua Medicine Dr. Chen Li was awarded the ‘C.C. Tan Life Science Industrialization Award’

HONG KONG, Oct 25, 2024 - (ACN Newswire via SeaPRwire.com) - The 17th “C.C. Tan Life Science Award” ceremony was held at Shenyang Pharmaceutical University on October 9th. Dr. Chen Li, Founder and Chief Executive Officer of Hua Medicine, was awarded the “C.C. Tan Life Science Industrialization Award”. C.C. Tan Life Science Award has the highest honor as “the Chinese Nobel” in life science. In the context of the comprehensive construction of Chinese-style modernization and the development of new productivity, this award is a high recognition of Dr. Chen Li's outstanding contributions to the industrialization of life science achievements, and a full affirmation of his decades-long efforts to promote conceptual, technological and institutional innovations in biopharmaceutical industry.Dr. Chen Li participated in the award ceremony and received the “C.C. TanLife Science Industrialization Award”.“C.C. Tan Life Science Award” was proposed by Mr. Tan Jiazhen, one of the founders of modern genetics in China and an outstanding scientist and educator in modern China, which was approved by the Ministry of Science and Technology of the People's Republic of China, aims to promote the industrialization of China's life sciences research results and stimulate life scientists to make innovations. Since its establishment in 2008, C.C. Tan Life Science Award has been awarded annually to scientists, professors and young scholars who have made achievements in life science in the People's Republic of China and have made outstanding contributions to the industrialization of scientific and technological achievements in life science.With more than 30 years of experience in new drug R&D and management, Dr. Chen Li returned to Shanghai from the U.S. in 2004, and participated in the establishment of Roche R&D Center, the first R&D center of a multinational company in Shanghai, bringing the advanced experience, talent concept, technical standards and quality management system of international new drug R&D to China, and contributing to the establishment of the environment of China's biopharmaceutical industry. Dr. Chen Li has contributed to the establishment of China's biopharmaceutical industry environment.In 2010, Dr. Chen Li founded Hua Medicine in Zhangjiang, Shanghai, with the original intention of “China leads the way in pharmaceutical innovation”, adhering to the tenet of “patients first, innovation first, and good medicines for the people”, focusing on the unmet clinical needs, and concentrating on the research and development of first-of-its-kind new medicines for diabetes. Dr. Chen Li is not only one of the earliest pioneers to leave his executive position at a multinational pharmaceutical company to start a local innovative drug company, but also a leader in developing First-in-Class drugs in China.In September 2022, under the leadership of Dr. Chen Li, Hua Medicine's world's first, China's first, Class I National New Drug, Dorzagliatin (trade name: HuaTangNing®), which took ten years to develop independently, received marketing approval from the State Food and Drug Administration (SFDA), making it the first Glucose Kinesin Activator (GKA) approved and marketed globally, and the tenth class of diabetes therapeutic drugs.As the world's first GKA drug, Dorzagliatin utilizes the new concept of “repairing sensing, reshaping homeostasis, and treating diabetes at the source” to achieve the improvement of blood glucose homeostasis dysregulation in patients with type 2 diabetes mellitus, and to bring a brand-new treatment for diabetes mellitus patients, which is a major breakthrough in the history of drug research and development of China in the field of major chronic diseases. During the development of Hua Medicine, Dr. Chen Li has actively contributed to the development of China's biopharmaceutical industry. He has provided constructive opinions and suggestions for the system of marketing license holders and the system of patent linkage and patent protection, etc. He has cooperated with enterprises in the industry chain in the R&D and production of dorzagliatin to establish a joint innovation model, which has led to the development of the ecological development of the biopharmaceutical industry. In early 2024, Dr. Chen Li was awarded the first “Shanghai Outstanding Talent”. He is also the inventor of 119 granted invention patents and 270 invention patent applications and has been published more than 70 scientific papers in Nature Medicine, Lancet Diabetes Endocrinology, Nature Communication, PNAS, Diabetes, Obesity Metabolism, and the Journal of Biomedicine. PNAS, Diabetes, Obesity Metabolism, JACS, JOC and other international academic journals.About Hua MedicineHua Medicine is an innovative drug development and commercialization company based in Shanghai, China, with companies in the United States and Hong Kong. Hua Medicine focuses on developing novel therapies for patients with unmet medical needs worldwide. Based on global resources, Hua Medicine teams up with global high-calibre people to develop breakthrough technologies and products, which contribute to innovation in diabetes care. Hua Medicine's cornerstone product HuaTangNing (dorzagliatin tablets), targets the glucose sensor glucokinase, restores glucose sensitivity in T2D patients, and stabilizes imbalances in blood glucose levels in patients. HuaTangNing was approved by the National Medical Products Administration (NMPA) of China on September 30th, 2022. It can be used alone or in combination with metformin on hydrochloride-tolerated T2D patients. For patients with chronic kidney disease (CKD), no dose adjustment is required. It is an oral hypoglycemic drug that can be used for patients with Type 2 diabetes with varying degrees of renal function impairment (including end-stage renal impairment without dialysis). Hua Medicine partnered with Bayer, a leading global pharmaceutical company, to commercialize HuaTangNing in China, benefiting diabetic patients and their families.For more informationHua MedicineWebsite: www.huamedicine.comInvestorsE-mail: ir@huamedicine.comMediaE-mail: pr@huamedicine.com Copyright 2024 ACN Newswire via SeaPRwire.com.
More
DIFC continues to drive global action in shaping greener economies – Announces 2nd edition of the Future Sustainability Forum in Dubai

DIFC continues to drive global action in shaping greener economies – Announces 2nd edition of the Future Sustainability Forum in Dubai

DUBAI, Oct 25, 2024 - (ACN Newswire via SeaPRwire.com) - Dubai International Financial Centre (DIFC), the leading global financial hub in the Middle East, Africa and South Asia (MEASA) region, announces the 2nd edition of the Future Sustainability Forum. Scheduled for 4 and 5 December 2024 at the Madinat Jumeirah, Dubai, the Forum will focus on mobilising sustainable practices, engaging in influential discussions on sustainable development, working towards environmental conservation, social equity and innovation.The announcement of the 2nd edition of the Forum underscores DIFC’s commitment to advancing UAE sustainability priorities alongside initiatives such as the DIFC Sustainable Finance Catalyst which aims to grow sustainable finance flows from Dubai to USD 100+ billion by 2030.The Forum coincides with the first anniversary of COP28 being hosted in the UAE and is set to attract over 3,000 participants. The event will mobilise industry leaders, investors, tech disruptors, and policymakers into achieving the United Nations Sustainable Development Goals (SDGs) and contributing to the delivery of the Paris Agreement, whilst aiming to channel investment flows between the global north and south to accelerate climate action.Alya Al Zarouni, Chief Operating Officer of DIFC Authority and Co-Chair of the Dubai Sustainable Finance Working Group, said, “The DIFC organised Future Sustainability Forum is a vital platform for collaborative action towards a more sustainable future. As the global economic landscape evolves, so must our commitment to responsible and inclusive growth. At DIFC, we are proud to be convening this gathering of industry leaders, innovators, and policymakers to address the most pressing environmental and social challenges of our time. Together, we can forge new pathways to a more resilient and sustainable future for financial services and other important industries.”Dr Bernd van Linder, Chief Executive Officer of the Commercial Bank of Dubai, the presenting sponsor of the Forum, stated, "Commercial Bank of Dubai is proud to support the UAE's sustainability ambitions through our participation in the Future Sustainability Forum 2024 as Presenting Sponsor. Our proactive approach in addressing environmental challenges, exemplified by the successful issuance of CBD's inaugural green bond, demonstrates our alignment with global environmental goals."The Forum will address critical sustainability issues across eight core pillars spanning different industries including banking and finance, construction, renewable and future energy, transportation and mobility, manufacturing and production, recycling and waste management, sustainable technology, and agriculture and food production.In addition to the packed conference agenda that will feature over 100 sustainability and climate action expert speakers, the Forum will bring together the most innovative solutions and service providers from across the global sustainability landscape through the Climate Action & Renewable Energy Expo (CARE).Government entities in the UAE have spearheaded a range of comprehensive sustainability programmes in the pursuit of a net-zero future. Initiatives such as the Dubai Clean Energy Strategy 2050, the UAE Net Zero 2050 strategic initiative, and the UAE Vision 2070, emphasise on a commitment to renewable energy adoption, water conservation, waste management, and sustainable urban development.For more information and to register, please visit the Future Sustainability Forum website.About Dubai International Financial CentreDubai International Financial Centre (DIFC) is one of the world’s most advanced financial centres, and the leading financial hub for the Middle East, Africa, and South Asia (MEASA), which comprises 77 countries with an approximate population of 3.7bn and an estimated GDP of USD 10.5trn.With a 20-year track record of facilitating trade and investment flows across the MEASA region, the Centre connects these fast-growing markets with the economies of Asia, Europe, and the Americas through Dubai. DIFC is home to an internationally recognised, independent regulator and a proven judicial system with an English common law framework, as well as the region’s largest financial ecosystem of 43,800 professionals working across over 6,150 active registered companies – making up the largest and most diverse pool of industry talent in the region. The Centre’s vision is to drive the future of finance through cutting-edge technology, innovation, and partnerships. Today, it is the global future of finance and innovation hub offering one of the region’s most comprehensive FinTech and venture capital environments, including cost-effective licensing solutions, fit-for-purpose regulation, innovative accelerator programmes, and funding for growth-stage start-ups. Comprising a variety of world-renowned retail and dining venues, a dynamic art and culture scene, residential apartments, hotels, and public spaces, DIFC continues to be one of Dubai’s most sought-after business and lifestyle destinations. For further information, please visit our website: difc.ae, or follow us on LinkedIn and X @DIFC.For media enquiries, please contact:Nivine William | Nisha CelinaBurson | bursonglobal.comnivine.william@bursonglobal.com | nisha.celina@bursonglobal.com Rasha Mezher | Dubai International Financial Centre Authority Manager, Marketing & Corporate CommunicationsRasha.Mezher@difc.ae Hussain AlZaabi | Dubai International Financial Centre AuthorityManager, DIFC Innovation Hubhussain.alzaabi@difc.ae Shadi DawiDirector - PR & Media+971 55 498 4989shadi@tresconglobal.com Copyright 2024 ACN Newswire via SeaPRwire.com.
More

HighTide Therapeutics to Present Analyses of Phase 2 MASH Study at AASLD’s The Liver Meeting 2024

HONG KONG, Oct 25, 2024 - (ACN Newswire via SeaPRwire.com) - HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for chronic liver and metabolic diseases, will present at the American Association for the Study of Liver Diseases’ (AASLD) The Liver Meeting®, taking place from November 15-19, 2024 in San Diego, California. The presentations include post-hoc analyses of the Phase 2a clinical study of berberine ursodeoxycholate (HTD1801), a gut-liver anti-inflammatory metabolic modulator, in patients with metabolic dysfunction-associated steatohepatitis (MASH) and comorbid type 2 diabetes mellitus (T2DM) (NCT03656744).“These data provide additional characterization of the efficacy and safety of HTD1801, a novel, multifunctional therapy being developed for the treatment of patients with MASH and T2DM. If further studies confirm these findings, HTD1801 could potentially offer a more effective solution for patients who do not respond adequately to GLP-1 receptor agonists. In addition, the observations of improved GI tolerance over time suggests that HTD1801 may be an attractive option for long-term management of chronic conditions such as MASH and T2DM. The ongoing Phase 2b study (CENTRICITY, NCT05623189), fully enrolled in 1Q 2024, evaluates the histological benefit of HTD1801 in patients with MASH and T2DM. We look forward to announcing the CENTRICITY results which we expect in the first half of 2025,” said Dr. Leigh MacConell, Chief Development Officer of HighTide.“Efficacy of Berberine Ursodeoxycholate (HTD1801) Compared to Ongoing Use of GLP-1 Receptor Agonists in Patients with MASH and T2DM” (Abstract 3218, Poster Presented November 17th)About the Abstract: As GLP-1 Receptor Agonists (GLP-1RAs) are prominently used in patients with T2DM and gaining attention as a potential treatment for MASH, this post-hoc comparative efficacy analysis evaluated ongoing GLP-1RA use compared to newly initiated HTD1801 treatment. This analysis suggests that HTD1801 provides greater improvements in markers of liver injury and inflammation, glycemic control, weight loss, and lipid metabolism compared to ongoing GLP-1RA use. These findings are important as they suggest that HTD1801 could provide additional benefit to patients with MASH and T2DM, on concomitant GLP-1RA treatment.“Time Course of Onset, Incidence, and Prevalence of Gastrointestinal Adverse Events with HTD1801 (Berberine Ursodeoxycholate) in Patients with MASH and T2DM” (Abstract 3219, Poster Presented November 17th)About the Abstract: Across several indications, the most commonly occurring adverse events (AEs) in studies of HTD1801 have been mild to moderate gastrointestinal (GI) AEs, primarily diarrhea and nausea. The purpose of this post-hoc analysis was to characterize the time course and severity of GI AEs in patients with MASH and T2DM treated with HTD1801 for 18 weeks. Based on this analysis, the incidence of GI-related AEs peaks within the first 4 weeks of treatment, was mild to moderate in severity, and importantly, showed a decreasing incidence and prevalence over the course of treatment. These data demonstrate that HTD1801 is generally well-tolerated and with continued treatment, GI tolerance improves supporting its potential long-term use in chronic diseases, such as MASH.About HighTide TherapeuticsHighTide Therapeutics, Inc. (2511.HK) is a globally integrated biopharmaceutical company focusing on the discovery and development of first-in-class multifunctional multi-targeted therapies with chronic liver and metabolic diseases with significant unmet medical needs. The company is developing multiple clinical assets, including therapy for metabolic dysfunction-associated steatohepatitis (MASH), type 2 diabetes (T2DM), severe hypertriglyceridemia (SHTG), and primary sclerosing cholangitis (PSC). Berberine ursodeoxycholate (HTD1801), the company’s lead drug candidate, received Fast Track designation from the U.S. FDA for both MASH and PSC, as well as Orphan Drug designation for PSC. In China, HTD1801 has been included in the National Major New Drug Innovation Program under the 13th Five-Year Plan for Major Technology Project.For more information, please visit www.hightidetx.com Copyright 2024 ACN Newswire via SeaPRwire.com.
More

君联投资企业地平线在香港联交所成功上市

香港, 2024年10月25日 - (亚太商讯 via SeaPRwire.com) - 据君联资本微信公号报道称,10月24日,联想控股(3396.HK)旗下君联资本所投智驾科技企业地平线(9660.HK)在香港联交所成功上市,地平线拟全球发行1,355,106,600股股份,其中香港公开发售135,511,200股,占约10%;国际配售1,219,595,400股,占约90%,另有超额配股权15%。截至发稿,地平线每股5.45港元,上市首日上涨36.59%,市值超过710亿港元。这标志著地平线作为一家智能驾驶解决方案的链主型领军企业,开启了全新"征程"。地平线是市场领先的乘用车高级辅助驾驶(ADAS)和高阶智能驾驶(AD)解决方案供应商,成立于2015年7月,创始人余凯博士,本硕毕业于南京大学电子科学与工程学系,长期在计算机工程领域深耕。地平线的产品包括征程系列芯片,这些芯片被广泛应用于智能驾驶领域,包括高级辅助驾驶(ADAS)和高阶智能驾驶(AD)解决方案。依托已大规模部署的前装量产解决方案,地平线已成为智能汽车转型及商业化的关键推动者。灼识咨询报告显示,自2021年起,按解决方案总装机量计算,地平线是首家且每年均为最大的提供前装量产的高级辅助驾驶和高阶智能驾驶解决方案的中国公司。地平线拥有庞大的全球客户群,包括行业领先的OEM(原始设备制造商)和国产汽车制造一级供应商,公司提供的解决方案整合了算法、专用软件和处理硬件,旨在提高驾驶安全性和乘客体验。截至2024年9月底,地平线累计定点车型290款、累计量产车型152款。目前,地平线征程家族车载智能计算方案出货量累计已突破600万套。2024年上半年,地平线营业收入9.3亿元,同比增长超150%。君联资本于2021年3月投资地平线,投资时地平线生产的智能驾驶芯片在各车企刚刚开始投入应用,投资后,公司产品持续迭代,研发生产了国内首款可量产的百TOPs级车载大算力智能驾驶芯片-征程5系列产品并形成批量生产应用,公司最新研发的征程6也持续量产并在各大车企销售。君联一路陪伴公司成长,在智能驾驶产业链上下游资源引荐等方面给予了公司支持和帮助。君联资本对地平线成功上市表示祝贺,随著汽车"智能化、网联化"的驱动,智能驾驶芯片已成为智能汽车智能驾驶的核心,地平线是行业内稀缺的有能力将算力在芯片产品上落地的企业,余凯博士带领的团队具有远大格局和前瞻性,有较强的商业落地能力和丰富的企业管理经验,随著我国智能汽车行业的持续增长,君联资本相信,上市后的地平线在智能驾驶领域将会持续拓展更广阔的市场和业务链条。智能驾驶技术是新质生产力的典型代表。君联长期实践科创投资,在人工智能、碳中和、半导体、数字经济、生物医药等国家战略性产业上密集投资,深入理解和融入国家创新型企业培育体系,持续推动所投企业面向解决"卡脖子"问题的重大创新方向,补链强链。君联资本作为联控旗下专注于早期创业投资以及成长期私募股权投资的专业投资机构,在二十多年的发展历程中,遵循国际通行标准,经历了多支基金的完整管理周期,创造了可持续的基金业绩。据其官网显示,已累计投资600多家企业,其中有113家在全球不同资本市场IPO退出,近100家通过并购退出。其所投企业中,既包括科大讯飞、宁德时代、药明康得、康龙化成这样的顶尖企业,也有大量的国家级专精特新小巨人和制造业单项冠军,构建了丰富的产业资源。 Copyright 2024 亚太商讯 via SeaPRwire.com.
More

侨雄国际否认媒体操纵股价质疑 称价格波动是市场对公司未来预期反应

香港, 2024年10月25日 - (亚太商讯 via SeaPRwire.com) - 针对公司近日股价持续上涨,引发媒体质疑涉嫌操纵股价的报导、侨雄国际(00381.HK)今日盘后发布公告称,经公司董事会作出一切合理查询后所知、所悉及所信,董事会坚决否认媒体报导中包含的猜测,并认为报导事项不准确且具有误导性。侨雄国际在公告中进一步指出,公司已经谘询其法律顾问,将会作出进一步行动。此外公司向负责传播误导性及恶意陈述,恶意沽空从而获益的有关实体及╱或相关个人及任何人,导致的损害或其他补偿,保留采取法律行动之权利。10月22日,有媒体发布题为《16个交易日翻了近30倍,侨雄国际(00381)全靠两个"经纪商"雄起?》,指出截至10月21日,中国北方证券和长桥证券两个经纪商近20个交易日分别净买入了0.92亿股和0.27亿股,持股比例分别为14.02%及3.42%,而其他经纪商仅有少量买入,由此质疑公司股价存在被操纵的嫌疑。侨雄国际执行董事兼联席主席李立中对媒体回应称,价格的波动是市场对公司未来预期的反应,是正常的市场行为。首先,乘著近期港股的升浪,很多公司股票都有明显的升幅。加上公司近来管理层的变动,委任了有丰富资历以及管理经验的董事,这些可被股东看作利好消息,公司股价上涨表示股东对公司前景乐观。二零二四年十月四日,侨雄国际委任李立中为执行董事兼联席主席。李立中长期从事人工智慧、元宇宙、智联网路、区块链科学研究,这些领域的研究成果不仅推动了科技进步,而且为人类的生活带来了巨大的改变。其工作成果向世界展示了中国科学家的智慧和实力,也为中国在科技领域的发展做出了重要贡献。侨雄国际表示,国家"十四五"规划中提出迎接数字时代,启动数据要素潜能,推进网络强国建设,加快建设数字经济、数字社会、数字政府,以数字化转型整体驱动生产方式、生活方式和治理方式变革。基于"十四五"规划所带来的数字化新浪潮,各行各业将获得更多发展机遇,面对中国社会经济发展新阶段、新特征,公司未来将专注于深化现有业务开发及运营,向数字媒体经销等方向稳定发展,丰富业务的多元化结构,使得公司更加稳步向前。侨雄国际在公告中表示,董事会经作出在相关情况下有关公司的合理查询后,董事会确认,其并不知悉导致价格或成交量波动的任何原因,或任何必须公布以避免公司证券出现虚假市场的资料。李立中强调,该报导仅凭市场交易券商名字片面的指责怀疑公司操纵市场,期间并未与上市公司做任何的沟通与确认,是典型恶意沽空的犯罪行为。公司会对其新闻前恶意做空行为和新闻后操纵市场行为发出律师函和诉讼,以维护广大投资者权益。前述媒体报导称,"侨雄国际基本面并不好,公司主要从事玩具及礼品制造及销售、天然资源勘探、水 果种植、休闲及文化及中草药多种业务,业务表现平淡,业绩收入已经连续两个半年度下行,且盈利能力持续下降。今年该公司业务模式并未有重大变化,唯一变化是在10月10日,拟将公司名称更名为权识国际集团(中文名称)。"侨雄国际近期发布公告,拟将公司名称更改为"AOM International Group Company Limited",并采用"权识国际集团股份有限公司"作为其第二中文名称。据悉,集团的业务有六大可呈报分类,由于各业务均有不同的经济特征,因此各业务被分开管理。对此李立中表示,侨雄国际更名为权识国际。未来会通过相关专利技术对公司各板块业务做全方位的数位经济转型,通过生产资料的标识化,为公司的各个板块注入新的价值与活力。因此引发股价上涨和投资者购买属于正常市场现象。李立中指出,目前侨雄国际的资金状况非常健康,公司管理层对公司发展的前景保持绝对的乐观态度,会考虑在未来继续增持公司股票,以带给市场及公司股东信心,稳定因为不实报道,故意抹黑而影响的公司股价。关于后续的业务安排,公司会按照上市公司管理要求走合规的业务流程正常公告披露。公司谨提醒公司股东及潜在投资者,关注公司于联交所网站(http://www.hkexnews.hk/index.htm) 。 Copyright 2024 亚太商讯 via SeaPRwire.com.
More
Formerra and H.B. Fuller Announce Strategic Partnership to Drive Growth in Advanced Bonding Solutions

Formerra and H.B. Fuller Announce Strategic Partnership to Drive Growth in Advanced Bonding Solutions

ROMEOVILLE, IL, Oct 23, 2024 - (ACN Newswire via SeaPRwire.com) - Formerra, a leader in performance materials distribution, announced today that it has been named a Platinum Partner in H.B. Fuller's Channel Partnership Program. This partnership positions the company to lead distribution efforts for H.B. Fuller's Cilbond® adhesives across North America and builds on over a decade of distribution success at Suministro de Especialidades ("Suministro"), a leading Mexican distributor acquired by Formerra in late 2023.Cilbond serves a variety of industries, including automotive applications that require rubber-to-metal bonds, such as suspension bushings, engine mounts, and anti-vibration systems.Suministro has played a pivotal role in advancing applications for Cilbond throughout Mexico. Formerra will complement this established relationship to deliver H.B. Fuller's innovative Cilbond bonding agents to the broader North American market, offering a unique combination of technical expertise, sustainable solutions, and customer support. Combined with Formerra's expansive reach, this will enable support for manufacturers in streamlining their processes and improving production.The Cilbond product line offers specialized bonding agents that cater to Power Grid, Transportation, Industrial, Oil, Gas & Mining industries, and more.Cilbond provides a variety of coating systems, ranging from the conventional two-coat system, known for its durability and bonding strength, to a cutting-edge one-coat system. Cilbond's one-coat options deliver a streamlined solution, saving both time and cost for customers. With additional water-based options, Cilbond aligns with the growing demand for more sustainable products, enabling manufacturers to reduce their potential environmental impact without sacrificing performance."Our new relationship with Formerra marks a significant step forward in our North American growth strategy," said Tim O'Neil, Managing Director at H.B. Fuller. "By combining Formerra's strong portfolio of complementary materials and technical expertise with our innovative technology, we're able to provide advanced solutions that meet the evolving needs of manufacturing customers. Together, we're well-positioned to help them increase efficiency, reduce costs, and meet sustainability goals.""We're confident that our deep technical capabilities, combined with Suministro's proven track record, position us to maximize the potential of this partnership for both parties," said Doug Zupan, Vice President of Operations at Formerra. "In bringing H.B. Fuller's innovative bonding solutions to the rest of North America, we intend to deliver exceptional value and support to our customers."About HB FullerAs the largest pureplay adhesives company in the world, H.B. Fuller's (NYSE:FUL) innovative, functional coatings, adhesives and sealants enhance the quality, safety and performance of products people use every day. Founded in 1887, with 2023 revenue of $3.5 billion, our mission to Connect What Matters is brought to life by more than 7,000 global team members who collaborate with customers across more than 30 market segments in over 140 countries to develop highly specified solutions that enable customers to bring world-changing innovations to their end markets. Learn more at www.hbfuller.com.About FormerraFormerra is a preeminent distributor of engineered materials, connecting the world's leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce capabilities, and ingenuity. The experienced Formerra team helps customers across multiple industries to design, select, process, and develop products in new and better ways - driving improved performance, productivity, reliability, and sustainability. To learn more, visit www.formerra.com.Contact InformationJackie MorrisMarketing Communications Manager, Formerrajackie.morris@formerra.com+1 630-972-3144SOURCE: Formerra Copyright 2024 ACN Newswire via SeaPRwire.com.
More
GMG Reaches Major Milestones in THERMAL-XR(R) Test Work

GMG Reaches Major Milestones in THERMAL-XR(R) Test Work

Brisbane, Queensland, Australia--(ACN Newswire via SeaPRwire.com - October 23, 2024) - Graphene Manufacturing Group Ltd. (TSXV: GMG) ("GMG" or the "Company") is pleased to provide a technical update on the commercialisation progress of THERMAL-XR® Powered by GMG Graphene.PRODUCT TECHNICAL UPDATETHERMAL-XR® has now successfully passed 15,000 hours for corrosion protection under a salt sea spray industry standard test (ASTM B117) in a third-party laboratory in the US as seen in Figure 1. The Company believes that THERMAL-XR® is one of the longest lasting corrosion protection coatings available on the market. The testing will continue, and further reports will be updated by the Company.Figure 1: THERMAL-XR® Coating Corrosion Test Results After 15,000 Salt Sea Spray Hours (ATM B117)To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/227525_ecd3ffa9c41478c4_001full.jpgGMG can now accurately model and calculate the heat transfer rate expected from THERMAL-XR®, as compared to bare (uncoated) Aluminium, within 1% of actual results. This was reviewed and verified by the University of Queensland.Figure 2 shows the simulation model used to calculate the heat transfer coefficients of bare aluminium, versus THERMAL-XR® coated aluminium, on the test rig that GMG built and operated to obtain the experimental data. The test was conducted at a temperature of approximately 100 degree Celsius.Figure 2: Estimation of Heat Transfer of THERMAL-XR® coated aluminium versus bare aluminiumTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/227525_gmg_figure2.jpgThrough this work, as shown in Figure 3, the Company has demonstrated that THERMAL-XR® provides approximately 8.6 times more radiative heat transfer than bare aluminium, due to its thermal radiation (passing of heat in wave forms) capabilities. THERMAL-XR® has been calculated to provide 8.15 W/m2K (Watts per metre squared Kelvin degrees), or approximately 1.44 Btu/hr ft2 F (British thermal units per hour foot squared Fahrenheit degrees), of heat transfer when applied properly on top of bare aluminium, as compared to 0.95 W/m2K or 0.17 Btu/hr ft2 for bare aluminium.Figure 3: Thermal Radiation calculations of THERMAL-XR® coated aluminium versus bare aluminiumTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/227525_ecd3ffa9c41478c4_004full.jpgFigure 4 shows THERMAL-XR® increases the overall heat transfer coefficient by 2.2 times more than bare aluminium, from 6.0 W/m2K up to 13.2 W/m2K because of the increase in the thermal radiation from the THERMAL-XR® coating. This was conducted at a temperature of approximately 100 degree Celsius for a 100mm diameter flat plate.Thermal Coefficient (W/m2K)Bare AluminiumTHERMAL-XR® Coated AluminiumThermal Radiation0.958.15Natural Convection (Air Cooling)5.085.08Total Heat Transfer6.013.2(2.2 Times)Figure 4: NATURAL Convection Overall Thermal Coefficient of THERMAL-XR® versus bare aluminiumFigure 5 shows that THERMAL-XR® provides approximately 27% more heat transfer when including FORCED convection (fan air cooling) over bare aluminium from 26.6 W/m2K up to 33.8 W/m2K because of the increase in the thermal radiation from the THERMAL-XR® coating. This was conducted at a temperature of approximately 100 degree Celsius and with modelling of the air speed at an approximate 5 metres/second.Thermal Coefficient (W/m2K)Bare AluminiumTHERMAL-XR® Coated AluminiumThermal Radiation0.958.15Forced Convection (Fan Air Cooling)25.7125.71Total Heat Transfer26.633.8(27% Increase)Figure 5: FORCED Convection Cooling Overall Thermal Coefficient of THERMAL-XR® versus bare aluminiumGMG's Managing Director and CEO, Craig Nicol, commented: "GMG continues to make good progress in testing THERMAL-XR® for corrosion protection and heat transfer - our increased understanding of the heat rejection rate of the product allows us to better recognise how it can be of potential value for various types of products in various applications and markets."GMG's Chairman and Director, Jack Perkowski, commented: "THERMAL-XR® testing in corrosion protection and heat transfer is highly translatable into so many industries - so it is great to see the progress."About THERMAL-XR® powered by GMG Graphene:THERMAL-XR® COATING SYSTEM is a unique method of improving the heat conductivity of corroded heat exchange surfaces and improving and maintaining the performance of new units at peak levels. The process coats and protects heat exchange surfaces increasing service life, while improving and rebuilding the lost corroded thermal conductivity and increasing the heat transfer rate by leveraging the physics of GMG Graphene, resulting in an efficiency improvement and a potential power reduction.THERMAL-XR RESTORE® is powered by GMG Graphene. PATENT PENDINGAbout GMG www.graphenemg.comGMG is a clean-technology company which seeks to offer energy saving and energy storage solutions, enabled by graphene, including that manufactured in-house via a proprietary production process. GMG has developed a proprietary production process to decompose natural gas (i.e. methane) into its elements, carbon (as graphene), hydrogen and some residual hydrocarbon gases. This process produces high quality, low cost, scalable, 'tuneable' and low/no contaminant graphene suitable for use in clean-technology and other applications.The Company's present focus is to de-risk and develop commercial scale-up capabilities, and secure market applications. In the energy savings segment, GMG has focused on graphene enhanced heating, ventilation and air conditioning ("HVAC-R") coating (or energy-saving coating), lubricants and fluids.In the energy storage segment, GMG and the University of Queensland are working collaboratively with financial support from the Australian Government to progress R&D and commercialization of graphene aluminium-ion batteries ("G+AI Batteries").GMG's 4 critical business objectives are:Produce Graphene and improve/scale cell production processesBuild Revenue from Energy Savings ProductsDevelop Next-Generation BatteryDevelop Supply Chain, Partners & Project Execution CapabilityFor further information please contact:Craig Nicol, Chief Executive Officer & Managing Director of the Company at craig.nicol@graphenemg.com, +61 415 445 223Leo Karabelas at Focus Communications Investor Relations, leo@fcir.ca, +1 647 689 6041Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release.Cautionary Note Regarding Forward-Looking Statements This news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends", "expects" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or will "potentially" or "likely" occur. This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, that the Company will continue testing THERMAL-XR® and provide further updates, that increased understanding of THERMAL-XR® will allow the Company to better recognize how it can add value in various types of products in various applications and markets, and that THERMAL-XR® testing in corrosion protection and heat transfer is highly translatable into many industries. Such forward-looking statements are based on a number of assumptions of management, including, without limitation, that the Company will continue to test THERMAL-XR® and provide updates, that an increased understanding of THERMAL-XR® will enable the Company to better identify how THERMAL-XR® can add value for various products in various applications and markets, and that THERMAL-XR® testing in corrosion protection and heat transfer is highly translatable into many industries. Additionally, forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of GMG to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: that the Company will not continue testing THERMAL-XR®, that the Company will not provide further updates regarding THERMAL-XR®, that a better understanding of THERMAL-XR® will not allow the Company to better recognize how it can add value in various types of products in various applications and markets, that THERMAL-XR® testing in corrosion protection and heat transfer will not be highly translatable into many industries, risks relating to the extent and duration of the conflict in Eastern Europe and its impact on global markets, the volatility of global capital markets, political instability, the failure of the Company to obtain regulatory approvals, attract and retain skilled personnel, unexpected development and production challenges, unanticipated costs and the risk factors set out under the heading "Risk Factors" in the Company's annual information form dated October 3, 2024 available for review on the Company's profile at www.sedarplus.ca.Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/227525 Copyright 2024 ACN Newswire via SeaPRwire.com.
More

Stable S&P rating supports Fosun’s globalization and innovation

HONG KONG, Oct 23, 2024 - (ACN Newswire via SeaPRwire.com) - HK equity market experienced snap adjustment rally in September, and is now entering stock picking phase before new round of catalyst arrives. Now is the period when investors explore resilient names whose fundamentals is robust enough to weather market turbulence. Fosun International (00656) fits into this category, with its continuous efforts on innovation and globalization, combined with solid delivery on financial result and attractive valuation.Fosun International is one of the few leading enterprises rooted in China with global operational capabilities. Since its establishment in 1992, Fosun International has built an industrial presence in more than 35 countries and regions worldwide, continually enhancing its global operational capabilities. It has now become a global innovation-driven consumer group.Enhancing innovation capabilities while delivering robust global operational capabilitiesOver past decades, Fosun has been enhancing and deepening its globalization capabilities via launching new products and advancing its international operation.Take pharmaceutical products for example, the biosimilar HANQUYOU has pioneered the international market expansion for Fosun. With licensing agreements covering approximately 100 countries and regions and marketing approvals in 48 countries and regions, HANQUYOU has become the China-developed biosimilar with the most marketing approvals.Thanks to the overseas expansion of biosimilars, Fosun has not only established its reputation internationally, but has also gained experience in the globalization of first-in-class drugs. HANZISHUANG, the world's first anti-PD-1 monoclonal antibody approved for the first-line treatment of small cell lung cancer (SCLC) independently developed by Shanghai Henlius, is an example of success. Fosun's overseas expansion of biopharmaceutical has resulted in the advancement of both first-in-class drugs and biosimilars. In 2023, Shanghai Henlius became the first first-in-class pharmaceutical company among its peers to achieve profitability through product sales.In terms of operations, Fosun International focuses on organization evolution and global resource integration. By leveraging regional advantages, it establishes a profound industrial presence and localized operations to continuously benefit its industries and brands.For example, in the tourism sector, Fosun Tourism Group (FTG) has achieved remarkable growth through its unique asset-light operating model, global presence and global operations. FTG's subsidiary Club Med, which operates 67 resorts worldwide, achieved a record-high business volume of RMB8.89 billion in the first half of 2024, representing a year-on-year increase of 10.3%. Its business in the Europe, Middle East and Africa (EMEA) region and the Americas continued to grow, while its business in Asia-Pacific region recovered significantly. In May 2024, Club Med signed an agreement in Oman for the launch of its first resort in the Middle East.Notably, there are very few domestic tourism companies that adopt an asset-light operating model and are equipped with global operational capabilities, making FTG a benchmark for the development of China's tourism industry. In addition, Fosun International continues to drive innovation and optimization in the consumption and insurance sectors, making positive impact on China's economic growth and industrial upgrades.As Fosun International enhances its focus on its "products + operations", its globalization capabilities are gradually bearing fruit, while its innovation capabilities are further developing. This approach has effectively strengthened its advantages in core industries such as tourism, consumption, pharmaceuticals, and insurance, garnering market optimism.S&P affirms Fosun International's "stable" rating outlook, noting that creditworthiness remains steadyRecently, Fosun International received further recognition in the international rating agencies. On 21 October, S&P released a report acknowledging Fosun's successful asset divestment and debt reduction efforts, assigning it a stable rating outlook.Specifically, S&P acknowledges the improvement of Fosun's liability structure, noting that bank loans now account for 73% of the holding company's debts, up from 46% in mid-2022. Fosun International completed a USD888 million offshore syndicate in September 2024, reflecting an increase in both bank participation and size compared to the syndicate due in May. S&P regards this as a clear evidence of recovery in offshore bank refinancing channels.The smooth access to financing channels reflects the confidence of domestic and international financial institutions in Fosun's financial position and business strategy. This not only reduces Fosun's reliance on public market financing but also allows for better support of liquidity management and greater flexibility to manage the pace of future asset divestment. S&P expects Fosun's asset recycling could continue to drive further debt reduction.The positive evaluation from S&P affirms Fosun International's strong execution of its globalization and innovation capabilities. Over the past two years, the remarkable improvement in its balance sheet and enhanced financial resilience have been evident. Additionally, this endorsement reinforces the company's investment value.Overall, as the outlook for the Chinese economy improves, especially with the implementation of key policy initiatives, the Hong Kong stock market holds significant growth potential. Thanks to its global presence, integrated innovation, and asset-light operating strategy, Fosun International is enhancing performance certainty and strengthening its financial resilience against risks. As its global operations continue to expand, industry-leading advantages strengthen, and the benefits of technology innovation accelerate, Fosun is poised to capitalize on the next wave of growth in the Hong Kong stock market. Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Asian Actuarial Conference 2024 Kicks Off in Hong Kong to Great Acclaims

Asian Actuarial Conference 2024 Kicks Off in Hong Kong to Great Acclaims

- HKSAR Under Secretary for Financial Services and the Treasury Joseph Chan honoured the event by delivering opening remarks- Returning after six years, the Asian Actuarial Conference 2024 receives overwhelming support from over 1,000 international professionals- Expertise of actuaries can reinforce Hong Kong’s capability as a premier risk management centre, therefore contribute to the resilience and sustainable growth of the cityHONG KONG, Oct 23, 2024 - (ACN Newswire via SeaPRwire.com) - The three-day Asian Actuarial Conference 2024 (AAC 2024) organised by the Actuarial Society of Hong Kong (ASHK), commenced today at the Ocean Park Marriott Hotel. This year's conference, themed “Exploring the Future of Insurance and Beyond: Innovation, International Hubs, and Hong Kong,” has more than 100 internationally renowned experts from diverse industries as speakers and panellists, and close to 1,000 participants including actuarial professionals, executives, and thought leaders from across Asia and beyond, making it a significant gathering in the actuarial community.Mr. Joseph Chan, Under Secretary for Financial Services and the Treasury of the HKSAR, officiated the opening ceremony together with Mr. Timothy Wong, President of the Actuarial Society of Hong Kong, Mr. Stephen Yiu, Chairman of the Insurance Authority, and Ms. Daisy Ning, Head Life & Health APAC ex China of Swiss Re.Timothy Wong, President of the ASHK, said, “We are delighted to have top business leaders in the region coming to Hong Kong to join AAC 2024, returning to the city after six years. Apart from allowing us, actuaries and insurers, to gain valuable insights on the evolving landscape of the professions, the Conference is also a vital platform for us to connect with practitioners in other professions that have wide-reaching implications for the future of ours. With the market changing so rapidly, it is essential for actuaries to stay abreast of latest industry developments and to unlock the vast potential of actuarial science to the benefit of diverse fields. Together, we are paving the way for growth of the actuary profession in Hong Kong.”Alongside technologies advancing at ever faster speed and with business opportunities of all kinds emerging in the Greater Bay Area, financial markets in the region have also become more complex and sophisticated. More companies are recognising the importance of financial planning and the need to effectively manage risks. Actuaries, equipped with a unique blend of analytical and business skills, are adept at helping businesses address diverse financial and social challenges. By developing models to assess the current financial implications of uncertain future events, they enable companies to make scientific and rational decisions.Also, taking into account the risk-based capital (RBC) regime for the Hong Kong insurance industry introduced on July 1 this year, plus the 2024 Policy Address just delivered by the Chief Executive of the HKSAR outlining ways to enhance development of the insurance sector, attract large enterprises to establish captive insurers in Hong Kong, and strengthen Hong Kong's position as a global risk management centre, actuaries are going to be in great demand in the near future.The government intends to examine capital requirements of and drive infrastructure investment, and enrich insurance companies' asset allocation for risk diversification, which are expertise areas of the actuarial profession, showing that actuaries have a pivotal role to play in ensuring the resilience and sustainable growth of the city.Simon Lam, Co-Chairperson Organising Committee Asian Actuarial Conference 2024 concluded, “As of December 2023, ASHK has a total of 1,293 members. With polices and regulations in its favour, ASHK, as the leading professional body for actuaries in Hong Kong, is ready to nurture more talent for the profession to meet the rising demand.”Day Two and Three of the AAC 2024 will explore important themes such as growth in emerging Asia, Hong Kong as an international hub, regulation, artificial intelligence, blockchain, ESG, professionalism, and more. The conference will conclude on Friday with excursions for delegates to visit the Greater Bay Area, Hong Kong Cyberport, Hong Kong Science Park, and the Palace Museum.For more information please visit: https://aac2024.hk/index About the Actuarial Society of Hong KongThe professional body for actuaries in Hong Kong was first formed in 1968 as the Actuarial Association of Hong Kong, its successor, the Actuarial Society of Hong Kong (ASHK) was later incorporated in 1994. It is governed by an elected Council with a President and 14 other Council Members. Fellow Members are entitled to use the FASHK designation which is a requirement for all Insurance Authority applications for Long-Term Appointed Actuaries and General Insurance Certifying Actuaries.The ASHK sets the Professional Standards outlined in the Insurance (Actuaries’ Standards) Rules (Cap. 41, section 129(1)) and the Actuarial Guidance Notes outlined in the various Insurance Authority Guidelines for the actuarial profession in Hong Kong. www.actuaries.org.hk About the Asian Actuarial ConferenceStarting from 2013, the Asian Actuarial Conference is usually a biennial event organised by an Asian Actuarial Association member organisation on a rotational basis. It has become the most important actuarial event in Asia. To date, the Asian Actuarial Association is made up of 12 actuarial organisations with close to 25,000 members. These member organisations come from* Australia, China, Chinese Taipei, Hong Kong, India, Indonesia, Japan, Malaysia, Singapore, South Korea, Thailand, and the Philippines.*In alphabetical order.From Left to Right:Mr. Simon Lam, Co-Chairperson Organising Committee Asian Actuarial Conference 2024Ms. Daisy Ning, Head Life & Health APAC ex China of Swiss ReMr. Stephen Yiu, Chairman of the Insurance AuthorityMr.Timothy Wong, President of the Actuarial Society of Hong KongMr. Joseph Chan, HKSAR Under Secretary for Financial Services and the TreasuryMr. Clement Cheung, CEO of the Insurance AuthorityMr. Alex Wong, Co-Chairperson Organising Committee Asian Actuarial Conference 2024Mr. Billy Wong, Co-Chairperson Organising Committee Asian Actuarial Conference 2024Mr. Joseph Chan, Under Secretary for Financial Services and the Treasury of the HKSAR, honoured the event by delivering opening remarksMr. Timothy Wong, President of the Actuarial Society of Hong Kong, welcomes over 1,000 professionals from across Asia andbeyond to join this significant actuarial conference Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Hong Kong International Optical Fair to open in November

Hong Kong International Optical Fair to open in November

- Over 700 exhibitors from 17 countries and regions to participate from 6-8 November at the Hong Kong Convention and Exhibition Centre- Exhibition reflects four prominent market trends: technology, lifestyle, functionality and sustainability- Concurrent Hong Kong International Optometric Symposium to explore latest breakthroughs in myopia control and prevention- Finalists of the 24th Hong Kong Eyewear Design Competition to be unveiledHONG KONG, Oct 23, 2024 - (ACN Newswire via SeaPRwire.com) - The 32nd Hong Kong International Optical Fair, organised by the Hong Kong Trade Development Council (HKTDC) and co-organised by the Hong Kong Optical Manufacturers Association (HKOMA), will take place on 6-8 November at the Hong Kong Convention and Exhibition Centre. Under the theme of Seeing is Believing, the Fair features innovative and state-of-the-art eyewear designs and products, bringing together industry players to facilitate new business opportunities.Sophia Chong, Acting Executive Director of the HKTDC emphasised: "This year’s Hong Kong International Optical Fair, a long-standing industry highlight for over 30 years, is more international than ever, attracting more than 700 exhibitors from 17 countries and regions. The fair reflects the dynamic evolution in eyewear design and technology. Exhibitors worldwide are aligning their products with key trends in technology, lifestyle, functionality and sustainability to capture expanded market opportunities. This exhibition, which is truly a feast for the eyes, demonstrates Hong Kong's advantages as an international trade and procurement centre."Hong Kong ranks as the world's third-largest exporter of eyewear and frames. The total export value of Hong Kong's eyewear, lenses and frames is estimated to have reached HK$19.9 billion in 2023, signalling substantial growth. The smart eyewear sector has emerged as an industry focal point, with the global market exceeding HK$40 billion in 2023 and projected to surpass HK$100 billion by 2029.Exhibitors from around the globe, including Europe and Americas, such as France, Germany, the United Kingdom and the United States, as well as Asia such as Japan, Korea, Malaysia, Singapore, Taiwan, and Türkiye in the Middle East, and more, will present their latest offerings at the fair. Prominent Hong Kong brands will also have a significant presence.This year’s Optical Fair will feature a number of group pavilions, including Mainland China, Japan, Korea and Taiwan, as well as the Visionaries of Style and HKOMA Pavilion; along with pavilions from cities in Mainland China, including Danyang in Jiangsu, Jiaojiang in Zhejiang, Shenzhen in Guangdong and Yingtan in Jiangxi.The Brand Name Gallery, the focal point of the Fair, will showcase over 200 renowned global brands. Other zones will present a broad spectrum of eyewear products, including Smart Eyewear, Contact Lenses & Accessories, Designer Café pavilion, Sporting & Professional Eyewear, Kids Eyewear & Reading Glasses, Lenses, Frames & Parts, Eyewear Accessories, Diagnostic Instruments, as well as Optometric Instruments, Equipment & Machinery.The 22nd Hong Kong International Optometric Symposium will be held on 7 November. Jointly organised by the HKTDC, the Hong Kong Optometric Association and The Hong Kong Polytechnic University, this year's symposium will focus on myopia control and prevention. Scholars from Mainland China, Hong Kong, Australia, and Germany will lead discussions with industry professionals. The symposium is a pre-approved CPD Programme recognised by the Optometrists Board and attendees will receive a Certificate of Attendance. The Fair will also offer talks and seminars on smart eyewear, functional eyewear, sustainability and other advancements in the eyewear industry.To foster Hong Kong’s creativity and innovation, the HKTDC and HKOMA will run the 24th Hong Kong Eyewear Design Competition under the theme of Be Bold. Results will be announced during the Hong Kong International Optical Fair. Winning and final entries will be on display at The Forum, Hall 1D during the fair period to showcase Hong Kong’s creativity to international buyers.Under the EXHIBITION+ hybrid model, exhibitors and buyers can meet online through the Click2Match business matching platform in addition to attending the physical fair until 15 November. Buyers can also use the Scan2Match feature of the HKTDC Marketplace App to scan the QR codes of exhibitors and view product materials, bookmark favourites, browse product information and floor plans, as well as engage with exhibitors before and after the fairs to continue their sourcing journey.Featured ProductsExhibitors at the forefront of the industry are unveiling an array of innovative eyewear products in line with technology, lifestyle, functionality and sustainability trends. Some of the highlighted products are:TechnologySolos AirGo Vision – Smart EyewearEquipped with a camera, AirGo Vision is the world's first smart eyewear with ChatGPT-4 functionality, and provides instant responses to what you see Solos Technology LimitedProduct Zone: Visionaries of Style Booth: GH-B26Reform EyewearReform features a new patented flexible frame technology that seamlessly adapts to any frame shape, size, colour or material, suitable for both prescription and sunglasses. This innovation offers endless possibilities for eyewear design, while ensuring safety and comfort.Icare (Hong Kong) Company LimitedProduct Zone: Hong Kong Optical Manufacturers Association Pavilion Booth: 1E-C08LifestyleFashion-Forward Yagioka EyewearThe local design brand Big Horn has launched the Yagioka eyewear line, featuring a modern and refined design that is perfect for fashion-forward people. This eyewear design was a finalist for the USA Accessories Council's Design Excellence Awards 2024.The Panda eyewear series draws inspiration for its colours and shapes from the beloved animal. Crafted with precision and made from high-quality biodegradable materials, it combines functionality with aesthetic appeal.Winky International LimitedProduct Zone: Brand Name GalleryBooth: GH-R03Rosie Allan – A Design for Both Parents and ChildrenEstablished in 2020, Rosie Allan transcends being just a brand; it celebrates family bonds and unforgettable moments. Specialising in 100% handcrafted acetate sunglasses, the matching parent-child collection symbolises love and togetherness.Rosie Allan Pty LtdProduct Zone: Brand Name GalleryBooth: GH-D07Luxury Jewellery-inspired Handcrafted EyewearThis Japanese brand merges high-end jewellery design with eyewear, utilising premium materials, such as 18K gold and natural diamonds. Each pair is meticulously handcrafted with a commitment to artisanal craftsmanship and is specifically designed for Asian facial features, exuding elegance.Inon Co. Ltd.Product Zone: Japan PavilionBooth: GH-B12Functionality:Nano Vista Children's Sports EyewearCrafted exclusively for kids and young athletes, Nano Vista - a Spanish brand - offers eyewear designed for outdoor activities. It is internationally recognised for safety, meets European EN166:2001 standards and is endorsed by top sports federations.Opticon LtdProduct Zone: Brand Name GalleryBooth: GH-C06Sustainability:Sustainable Eyewear Frame SolutionThe eyewear frames are made from BioCell material. BioCell is a cellulose acetate derived from cotton or wood pulp, certified as biodegradable according to ISO 14855 standards. It contains no industry-standard plasticisers and is compatible with polycarbonate lenses.Eleung LimitedProduct Zone: Hong Kong Optical Manufacturers Association PavilionBooth: 1E-D14Eco-Friendly Nylon and PC LensesEco-friendly nylon and polycarbonate (PC) lenses are produced using sustainable materials, reducing carbon emissions during the manufacturing process. They feature high abrasion and scratch resistance and have received multiple certifications. Even in low-temperature conditions, they maintain hardness and toughness, providing excellent clarity and optical transmission performance.Mellan LimitedProduct Zone: Frames & PartsBooth: 1E-C28 Last year’s Hong Kong International Optical Fair was a great successPhoto download: https://bit.ly/3NzTZIrWebsites:The 32nd Hong Kong International Optical Fair:https://www.hktdc.com/event/hkopticalfair/enEvent Details of the Hong Kong International Optical Fair: https://www.hktdc.com/event/hkopticalfair/en/intelligence-hub The 22nd Hong Kong International Optometric Symposium: https://www.hktdc.com/event/hkopticalfair/en/the-22nd-hong-kong-international-optometric-symposiumThe HKTDC’s Media Room: http://mediaroom.hktdc.com/enFair Details (Physical)Date:6 – 8 November (Wednesday to Friday)Time:(6 to 7 November) 9:30am – 6:30pm(8 November) 9:30am – 5:00pmVenue:Hong Kong Convention and Exhibition CentreAdmission:For trade visitors aged 18 or above only. Onsite Registration Fee: HK$100 per person (free for e-Badge registration and pre-registered buyers)Click2Match – Smart Business Matching PlatformDate:30 October – 15 NovemberMedia enquiriesPlease contact the HKTDC’s Communications and Public Affairs Department:Johnny TsuiTel: (852) 2584 4395johnny.cy.tsui@hktdc.orgSharon HaTel: (852) 2584 4575sharon.mt.ha@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2024 ACN Newswire via SeaPRwire.com.
More